Company: IPSI
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001213900-25-026455
Chunk: 1866

Company: Innovative Payment Solutions, Inc.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 10
Chunk 1866
---
for managing over 50 brokers and was subsequently hired by Lehman Brothers where he was one of the top producers in the 1990’s.
In 1995, he co-founded and became CEO of The Shemano Group, a San Francisco investment banking boutique, which developed into one
of the leading banks for funding small cap companies. Mr. Corbett was a managing director at Paulson Investment Co. from October 2013
until October 2016, responsible for West Coast investment banking activities. He also has served as CEO of DPL a lending company,
and a wholly owned subsidiary of DPW Holdings, Inc., from October of 2016 until May 2019.

Mr. Corbett’s
financial experience on Wall Street, specifically with micro-cap companies, we believe provides him with the attributes that make
him a valuable member of the Company’s Board of Directors.

Richard Rosenblum, President,
Chief Financial Officer, Secretary and Director. Mr. Rosenblum has been serving as the Company’s President, Chief Financial
Officer and a Director since July 22, 2021. Mr. Rosenblum has also served as the Secretary of the Company since August 26,
2021.

Richard Rosenblum has
been, since its founding in 1994, Chief Executive Officer and Principal at Harborview Capital Advisors LLC (“Harborview”),
which provided strategic advisory services in the areas of capital formation, merchant banking and management consulting. Additionally,
Mr. Rosenblum has been the owner of Harborview Property Management (“HPM”) for over twenty-five (25) years,
where he invests and manages domestic and international commercial real estate, and multi-family real-estate assets. From 2008
to 2014, Mr. Rosenblum was a Director, President and Executive Chairman of Alliqua Biomedical Inc. (NASDAQ: ALQA), which developed
and marketed hydrogel manufacturing technology in the wound care sector. His philanthropic and community-centered activities include
being a founding board member of the Dr. David Feit Memorial Foundation (DFM), which for over 15 years raised money for the
benefit and support of youth activities. Since 2018. Effective January 17, 2022, Mr. Rosenblum was appointed as an independent director
to the board of H-Cyte, Inc. H-CYTE is a medical bios